Wednesday, June 17, 2015
The ent-kaurene class of natural products are diterpenoids that are formed as secondary metabolites in higher plants of the genus Stevia and Isodon. Steviol diterpenoids and glycosides thereof accumulate in the leaves of Stevia rabaudiana at high concentrations and the plant extracts are marketed as ‘Stevia,’ a natural low-calorie sweetener. At this site, we’ve discussed Stevia’s prominent role in a key plot point on the show Breaking Bad. We’ve also covered synthetic aspects related to cafestol, an ent-kaurene diterpenoid found in coffee drinks. Now Corinna Schindler’s group at the University of Michigan has contributed an outstanding Review Article in the journal Tetrahedron that presents an authoritative overview of ent-kaurene isolation, biosynthesis, antibacterial and antitumor activity. The manuscript also provides a comprehensive account of synthetic strategies (dating back to Bob Ireland’s work in 1966!) used access ent-kaurene diterpenoids in a laboratory setting. Prior to reading this Review, I’ll admit that I was not aware of (and could not find in the scientific literature…not for a lack of searching) the reason for adding the ‘ent-’ prefix to the ‘ent-kaurene’ natural products. Schindler et al clear that up in two sentences:
“In 1999, kaurene was classified as the fundamental parent structure of this subclass of diterpenoids by the IUPAC. Despite this nomenclature, the vast majority of kaurene diterpenoids isolated to date belong to the ent-kaurenes, in which all asymmetric centers undergo configurational inversion…”
Sunday, June 14, 2015
Certain benthic marine organisms have served as an abundant source of architecturally diverse secondary metabolites for natural products chemists. Structural classes derived from marine sources include various types of peptides, neurotoxic alkaloids and halogenated sesquiterpenes, to name a few. The most common explanation for this phenomenon of chemical ecology is that marine invertebrates such as mollusks and sponges, which are shell-less and have soft, unprotected body tissues, rely on chemical defense substances to deter potential predators. Other postulated roles for co-occurring chemical defense molecules include prevention of fouling, inhibition of overgrowth and protection from ultraviolet radiation. An alternate hypothesis is that some secondary metabolites serve no function at all and are simply representative of accumulations of enzymatic side products or have served as deterrents toward ancient predators that have since gone extinct. Regardless, marine invertebrates have provided a vast supply of bioactive molecules for the eventual discovery and development of new pharmacological tools and therapeutic agents.
Recently, in the journal Angewandte Chemie International Edition (ACIE), Hideo Kigoshi and co-workers reported the structural assignment of a new ‘seco-’ (defined as ring-fragmented) steroid, isolated from a type of marine gastropod mollusk commonly referred to as a ‘sea hare.’ Interestingly, certain sea hares are known for the unique ability to discharge a colorful, sticky ink when threatened. The defensive ink’s chemical composition induces sensory inactivation in predators such as spiny lobsters. Kigoshi’s team at the University of Tsukuba in Japan disclosed the chemical structure of aplysiasecosterol A (see Table above, top panel), a 9,11-secosteroid isolated from the marine sea hare Aplysia kurodai. The tricyclic g-diketone skeletal framework of aplysiasecosterol A is unprecedented and a compelling biosynthetic pathway starting from a derivative of cholesterol was proposed by the authors. The new degraded steroid exhibits modest cytotoxicity against the human myelomonocytic leukemia cell line HL-60 (IC50 = 16 uM). The eastern substructure of aplysiasecosterol A, encompassed by the characteristic steroid D-ring and cholestane-type side chain, is reminiscent of the long-known polyhydroxylated sponge-derived 9,11-secosterol, herbasterol. The fascinating and ornate structure of herbasterol was characterized in 1985 by Capon and Faulkner (Scripps Institute of Oceanography) and, to my knowledge, has never been synthesized by chemical means. Aplykurodinone-1 is another marine secosteroid that has generated intense interest (for a leading reference, see here) amongst synthetic chemists, dating back to its prominent inaugural total synthesis in 2010 by Sam Danishefsky’s group. Aplykurodinone-1 was isolated from the sea hare Syphonota geographica from the Mediterranean Sea off the Greek coast and can be broadly classified as an oxidatively degraded steroid with cytotoxic bioactivity against a range of human cancer cell lines. The related aplykurodins (Table above, bottom panel) are a group of ichthyotoxic lactones that were isolated from marine mollusks of the genus Aplysia in the late 1980s to early ‘90s. Additional biochemical screening efforts will likely uncover new pharmacological properties and cellular targets for marine secosterols that may be pertinent to drug discovery programs.
Saturday, June 6, 2015
Masayuki Inoue’s laboratory at the University of Tokyo has been publishing some really great synthetic work over the last few years. For example, their review of convergent total syntheses of complex terpenoids that appeared earlier this year in Chemical Reviews serves as an excellent overview of modern academic campaigns directed toward the synthesis of important bioactive targets including limonoids, cardenolides and taxanes. In 2014, the group disclosed an impressive 22-step synthesis of ryanodol (structure shown above), a botanical insecticide with a stereochemically complex polycyclic molecular architecture. Ryanodol is interesting from an agrochemical perspective because it exhibits highly selective toxicity to insects and its biological mechanism of action may be unique from that of its better-known pyrrole-2-carboxylate ester, ryanodine.
Earlier this year in the journal, Chemical Science, Inoue and co-workers reported a new de novo synthesis of the classical steroidal target, ouabagenin. Ouabagenin and its C3-O-glycosylated parent structure, ouabain, are high-affinity ligands for the membrane-bound sodium pump, Na+/K+-ATPase. The chemistry and biology of ouabain and related cardenolides has been reviewed [here] and discussed previously at this site. Only one total synthesis of ouabagenin (by Deslongchamps’ group) predates that of Inoue and required ~41 steps. Inoue’s new total synthesis is slightly shorter and can be considered more modular, due to its highly convergent nature. Three critical building blocks were assembled by Inoue et al in the course of their total synthesis campaign. These fragments corresponded to the functionalized cardiotonic steroid butenolide (lactone moiety), A/B decalin and D-ring substructures. The C-ring was fashioned at a late stage by a stereocontrolled aldol reaction that simultaneously establishes the stereochemical configurations at C8, C13 and C14. For a more detailed analysis of Inoue’s overall strategy for cardenolide synthesis, see here.
Construction of the highly oxygenated A/B-ring fragment, along with identification of a suitable protecting group strategy for its polyhydroxylated array of functionality, is the most challenging aspect of a strategy for ouabain total synthesis. Synthesis of Inoue’s decalin substructure begins with a Diels-Alder reaction between (R)-perillaldehyde and Rawal’s diene. Further elaboration of the resultant cis-decalin provides the bicyclic dienone shown in the Scheme above. A challenging stereoselective ketone reduction was required to establish a directing group at C3 that would later deliver functionality to steroid carbons 1 and 5, exclusively from the top face. The C3-b-alcohol was obtained with moderate stereoselectivity (d.r. 3:1) by a ketone reduction with a chiral hydride reagent prepared from lithium aluminum hydride. Subsequent exposure of the resultant triene to mCPBA then induced a unique triple epoxidation, wherein the olefins adjacent to C3 were epoxidized exclusively from the b-face due to anchimeric assistance. Next, an oxidation/reduction sequence selectively opened the two epoxides proximal to the C3 ketone to give a diol intermediate. The requisite C1/C3/C5-triol was obtained using DIBAL-H, which reduced the C3 ketone from the bottom face and fragmented the remaining epoxide in a regioselective fashion. The three cis-hydroxy groups were then cleverly protected as an orthoester. Finally, the tertiary alcohol appended to the eventual steroid B-ring was converted to an a,b-unsaturated carbonyl by a three-step sequence involving dehydration, oxidative cleavage of the exocyclic olefin and dehydrogenation. Desilylation with fluoride completed the 15-step synthesis of the ornate A/B decalin fragment.
The A/B decalin substructure was stereoselectively functionalized at C9 by implementation of a 6-exo radical cyclization protocol that ultimately furnished the critical aldol substrate depicted above. Closure of the steroid C-ring by means of an aldol reaction is well-precedented. One such example that is highlighted in Inoue’s review of terpenoid total synthesis is from Deslongshamps’ 2008 total synthesis of (-)-ouabain (aldol transformation outlined above). Inoue’s aldol approach is somewhat more ambitious in that it attempts to control three stereocenters in a single operation due to the meso nature of the D-ring substructure. A desymmetrization of this nature could theoretically generate up to eight distinct diastereomeric products. However, perhaps due to subtle stereoelectronic properties imparted by the acetal-containing linker of Inoue’s substrate, the base-mediated aldol cyclization, in this example, delivered the desired stereoisomer as the major product (65%), along with a minor 13,14a-diastereomer (8%). The major aldol product was next deoxygenated at C7 by a standard three-step sequence.
The Inoue group’s endgame parallels that of Baran’s recent partial synthesis of ouabagenin to a certain extent (comparison delineated in the Scheme above). However, the relative simplicity and straightforward nature of Inoue’s approach, in my opinion, renders it preferable (and perhaps more scalable). For example, in both cases, the butenolide lactone is appended to C17 by means of an optimized Stille coupling. However, the Stille strategy necessitates the non-trivial task of subsequently installing the correct configuration at C17 by reducing the D16,17 olefin from the concave a-face. For this, Baran resorted to screening various superbases to isomerize a tetrasubstituted olefin that was, itself, generated by a cobalt boride-mediated reduction of the dienoate-Stille product. Ultimately, Barton’s base (BTMG) was demonstrated to deliver the correctly configured 17b-enoate with moderate stereoselectivity (d.r. 3:1). Global deprotection with methanolic HCl then furnished semisynthetic ouabagenin. Inoue’s solution to the C17 problem is far more intuitive. Exhaustive silylation of their Stille product produces an advanced intermediate that is capable of blocking the approach of reducing agents from the b-face. In this case, a simple palladium on carbon-catalyzed hydrogenation of the silylated penultimate precursor, followed by global deprotection, is sufficient to secure fully synthetic ouabagenin. To date, a total of three laboratories have successfully generated synthetic ouabagenin, since the isolation of ouabain by Arnaud 27 years ago in 1988. This timeline clearly serves as a testament to the three-dimensional complexity of highly oxygenated steroids such as ouabain. Deslongchamps, Inoue and Baran [see also here] have provided interesting solutions to the ouabain problem, each with varying degrees of practicality.